Hemab Therapeutics Holdings Ownership | Who Owns Hemab Therapeutics Holdings?
Hemab Therapeutics Holdings Ownership Summary
Hemab Therapeutics Holdings is owned by 120.52% institutional investors, 10.78% insiders. Ra capital management is the largest institutional shareholder, holding 25.93% of COAG shares. American Funds SMALLCAP World A is the top mutual fund, with 7.51% of its assets in Hemab Therapeutics Holdings shares.
COAG Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Hemab Therapeutics Holdings | 120.52% | 10.78% | -31.30% |
| Sector | Healthcare Stocks | 247.07% | 12.15% | -159.22% |
| Industry | Biotech Stocks | 385.89% | 11.79% | -297.68% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 7.81M | 25.93% | $286.81M |
| Novo | 4.18M | 13.88% | $153.55M |
| Fmr | 3.72M | 12.36% | $114.80M |
| Deep track capital, lp | 3.60M | 11.96% | $132.30M |
| Capital investors | 3.60M | 11.96% | $111.07M |
| Siren | 2.37M | 7.86% | $72.97M |
| Avoro capital advisors | 1.93M | 6.39% | $70.71M |
| Bain capital life sciences investors | 1.65M | 5.48% | $60.60M |
| Jpmorgan chase | 932.86K | 3.10% | $30.41M |
| State street | 927.25K | 3.08% | $28.60M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Novo | 4.18M | 8.92% | $153.55M |
| Bain capital life sciences investors | 1.65M | 3.60% | $60.60M |
| Ra capital management | 7.81M | 2.49% | $286.81M |
| Deep track capital, lp | 3.60M | 1.93% | $132.30M |
| Siren | 2.37M | 1.72% | $72.97M |
| Rock springs capital management lp | 575.43K | 1.03% | $21.14M |
| Avoro capital advisors | 1.93M | 0.64% | $70.71M |
| Bellevue group | 550.00K | 0.43% | $20.20M |
| Affinity asset advisors | 138.03K | 0.23% | $5.07M |
| Braidwell lp | 160.00K | 0.22% | $5.88M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | 7.81M | 2.49% | 7.81M |
| Novo | 4.18M | 8.92% | 4.18M |
| Deep track capital, lp | 3.60M | 1.93% | 3.60M |
| Avoro capital advisors | 1.93M | 0.64% | 1.93M |
| Bain capital life sciences investors | 1.65M | 3.60% | 1.65M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jpmorgan chase | 932.86K | 0.00% | -219.56K |
| Abrdn | - | - | -52.12K |
| Ensign peak advisors | 96.45K | 0.00% | -18.95K |
| Landscape capital management | - | - | -13.18K |
| Squarepoint ops | - | - | -6.25K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ra capital management | 7.81M | 2.49% | 7.81M | $286.81M |
| Novo | 4.18M | 8.92% | 4.18M | $153.55M |
| Deep track capital, lp | 3.60M | 1.93% | 3.60M | $132.30M |
| Avoro capital advisors | 1.93M | 0.64% | 1.93M | $70.71M |
| Bain capital life sciences investors | 1.65M | 3.60% | 1.65M | $60.60M |
Sold Out
| Holder | Change |
|---|---|
| Squarepoint ops | -6.25K |
| Landscape capital management | -13.18K |
| Abrdn | -52.12K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 56 | - | 36,291,239 | - | 120 | - | 56 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 3.51M | 7.51% | - |
| Fidelity Growth Compy Commingled Pl S | 691.58K | 1.48% | - |
| Vanguard Morn Total Stk Mkt Idx Investor | 555.54K | 1.19% | 523.56K |
| Vanguard MStar Total Stk Mkt Idx Invest | 555.54K | 1.19% | - |
| State Street® SPDR® S&P® Biotech ETF | 552.48K | 1.18% | 14.45K |
| Fidelity Growth Company Fund | 523.85K | 1.12% | - |
| iShares Russell 2000 ETF | 501.67K | 1.07% | - |
| Fidelity Select Biotechnology | 439.48K | 0.94% | - |
| JPMorgan Small Cap Growth A | 426.26K | 0.91% | -16.72K |
| Fidelity Stock Selector Small Cap | 383.45K | 0.82% | -56.50K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | - |
COAG Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools